Collaborator: Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

• Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls

• Frequency and clinical features of germline pathogenic variants in sarcoma: A case-control study

• SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohort

• Time to testing for hereditary cancer: A comparison of age at cancer diagnosis and genetic testing

  Presenting Author: Magan Trottier, MS, CGC Take home points:  Significant Delays Exist Between Cancer Diagnosis and Genetic Testing: Across most cancer types, patients experience a lag of 2–4 years between diagnosis and hereditary cancer genetic testing. The longest delays were observed in ovarian (4.0 years) and kidney cancers (3.9 years), with particularly concerning delays for ovarian…

  April 2, 2026

• Understanding how gene-disease relationships can impact clinical utility: adaptations and challenges in hereditary cancer testing

• Low allele frequency variants identified on germline multi-gene panel testing for cancer predisposition can suggest the presence of constitutional mosaicism